ADVANCING CANCER THERAPIES THROUGH THE ONE HEALTH APPROACH: THE ROLE OF VETERINARY AND COMPARATIVE ONCOLOGY IN HUMAN AND ANIMAL PATIENT CARE

Authors

  • Klementina Fon Tacer Texas Tech University School of Veterinary Medicine; Texas Center for Comparative Cancer Research, Amarillo, Texas, USA, fontacer@ttu.edu

DOI:

https://doi.org/10.26873/SVR-2182-2024

Abstract

The landscape of human health problems in the last several decades has markedly changed due to life sciences development. Non-communicable (chronic) diseases have become the leading causes of death, with several types of cancer ranking among the top causes globally (1). As in humans, and also in veterinary medicine, the landscape of the disease burden is changing. In small animal practice in particular.  Cancer is among the most common causes of death for dogs (and cats) in the developed world, even though it is uncommon in wildlife and other domestic animals (2). Dogs get cancer at roughly the same rate as humans, while there is less information about the rate of cancer in cats.

Napredek pri zdravljenju raka z uporabo pristopa Eno zdravje: vloga veterinarske in primerjalne onkologije pri zdravljenju ljudi in živali

Izvleček: V zadnjih desetletjih je zaradi napredka v znanosti o življenju prišlo do pomembnih sprememb v razumevanju in obravnavi zdravstvenih težav pri ljudeh. Nenalezljive (kronične) bolezni so postale vodilni vzrok smrti, pri čemer se več vrst raka uvršča med glavne vzroke smrtnosti na globalni ravni (1). Podobno kot pri ljudeh se tudi v veterinarski medicini spreminja narava bremena bolezni, zlasti v praksi malih živali. V razvitem svetu je rak eden najpogostejših vzrokov smrti pri psih (in mačkah), medtem ko se pri divjih živalih in drugih domačih vrstah redko pojavlja. Pojavnost raka pri psih je primerljiva s tisto pri ljudeh, medtem ko je podatkov o pogostosti raka pri mačkah manj.

References

Čater M. Interdisciplinary approaches for oncological treatments: pro¬ton therapy at the intersection of physics and medicine. Slov Vet Res 2024; 61(1): 5–8. doi: 10.26873/SVR-1957-2024

Florke Gee R, Fon Tacer K. Advancing cancer diagnosis and therapy through collaboration and comparative research. Panhandle Health 2024; 34: 19–21.

Miller KD, Nogueira L, Devasia L, et al. Cancer treatment and survi¬vorship statistics, 2022. CA Cancer J Clin 2022; 72(5): 409–36. doi: 10.3322/caac.21731

Rajčević U, Smole A. Preclinical mouse models in adoptive cell therapies of cancer. Slov Vet Res 2022; 59(4): 173–84. doi: 10.26873/SVR-1513-2022

Sarver AL, Makielski KM, DePauw TA, Schulte AJ, Modiano JF. Increased risk of cancer in dogs and humans: a consequence of recent extension of lifespan beyond evolutionarily-determined limitations? Aging Cancer 2022; 3(1): 3–19. doi: 10.1002/aac2.12046

Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature 2019; 575(7782): 299–309. doi: 10.1038/s41586-019-1730-1

WHO. Geneva: World Health Organisation, 2024. https://www.who.int/ (20. 12. 2024).

Downloads

Published

2025-02-28

How to Cite

Fon Tacer, K. (2025). ADVANCING CANCER THERAPIES THROUGH THE ONE HEALTH APPROACH: THE ROLE OF VETERINARY AND COMPARATIVE ONCOLOGY IN HUMAN AND ANIMAL PATIENT CARE. Slovenian Veterinary Research, 62(27-Suppl), 5–7. https://doi.org/10.26873/SVR-2182-2024

Issue

Section

Editorial